Enrique J. Arenas
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer.
Journal: Molecular oncology
Published: September 19, 2025
Cytokine-driven cancer immune evasion mechanisms.
Journal: International review of cell and molecular biology
Published: July 23, 2025
Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 27, 2024
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models.
Journal: Genome medicine
Published: February 13, 2024
AXL - a new player in resistance to HER2 blockade.
Journal: Cancer treatment reviews
Published: July 26, 2023
Early-Stage Breast Cancer Detection in Breast Milk.
Journal: Cancer discovery
Published: February 11, 2023
Evaluation of triple negative breast cancer with heterogeneous immune infiltration.
Journal: Frontiers in immunology
Published: January 22, 2023
Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 16, 2022
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer.
Journal: Science advances
Published: May 20, 2022
The target antigen determines the mechanism of acquired resistance to T cell-based therapies.
Journal: Cell reports
Published: November 02, 2021
Last Updated: 09/26/2026